Table of Contents
<< Previous Issue | Jul 2013 (Vol: 2013, Issue: 7) | Next Issue >> |
- Section: Licensing
-
Questcor Eliminates Competition for H.P Acthar® Gel with Novartis Deal
-
Cytokinetics Gains Astellas as Partner in Field of Skeletal Muscle Activation
-
Celgene Adds Antibody to Multiple Myeloma Pipeline with MorphoSys Deal
-
Avanir Licenses North American Rights to OptiNose’s NDA-Ready Drug-Device Combination for Migraine
- Section: Mergers & Acquisitions
-
J&J Gains Successor to Zytiga® with Aragon Pharmaceuticals Acquisition
-
AstraZeneca Strengthens Core Respiratory Business with US$1.15 B Pearl Therapeutics Purchase
-
Teva Expands Respiratory Pipeline with MicroDose Therapeutx Purchase
-
Aspen Pharmacare Continues Global Expansion with Deal to Acquire Merck & Co. API Business
- Section: Research & Development
-
Seattle Genetics and Bayer Partner for a Second Time to Develop Antibody-Drug Conjugates
-
Immunocore’s ImmTAC ® Platform Gains Big Pharma Recognition with Genentech Pact